论文部分内容阅读
鼻咽癌是一种多发性、常见的头颈部肿瘤。随着医疗技术的飞速发展,现今许多专家学者开始注重研究鼻咽癌患者的个体化综合治疗,利用多学科治疗模式,来提高该病的“治愈率”。目前,鼻咽癌最有效的治疗方法是放疗或者以放疗为主的综合性治疗,临床上会因远处转移或者局部复发的因素,造成治疗失败。而分子靶向治疗在治疗鼻咽癌中占有非常高的分量,已经成为有效提高鼻咽癌患者生存的希望。
Nasopharyngeal carcinoma is a multiple and common head and neck cancer. With the rapid development of medical technology, many experts and scholars nowadays pay more attention to individualized comprehensive treatment for patients with nasopharyngeal carcinoma, and use the multidisciplinary treatment model to improve the cure rate of the disease. Currently, the most effective treatment for nasopharyngeal carcinoma is radiotherapy or radiotherapy-based comprehensive treatment, clinically due to distant metastasis or local recurrence of factors, resulting in treatment failure. The molecular targeted therapy in the treatment of nasopharyngeal carcinoma occupies a very high weight, has become an effective way to improve the survival of patients with nasopharyngeal carcinoma hope.